Enliven Therapeutics, Inc. (ELVN)
27.90
+0.70
(+2.55%)
USD |
NASDAQ |
Jan 22, 11:50
Enliven Therapeutics EPS Diluted (Quarterly): -0.3245 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Coherus Oncology, Inc. | -0.3021 |
| Allogene Therapeutics, Inc. | -0.1864 |
| Pyxis Oncology, Inc. | -0.3517 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.15M |
| Total Expenses (Quarterly) | 20.15M |
| Enterprise Value | 1.137B |
| Earnings Yield | -6.62% |
| Normalized Earnings Yield | -6.616 |